Taysha Gene Therapies, Inc.TSHA stock score: 47/100

$3.77 · -5.51% · Scored Nov 19, 2026

Technical
33
Fundamental
51
News
55

The reading

Taysha Gene Therapies (TSHA) scores 47 out of 100, which reads weak, higher than 41% of Healthcare stocks and 39% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 51, technicals 33.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 21 and contrarian oscillators 64 — a split worth reading before trusting the technical total.

News sentiment is neutral at 55; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 37 to 51, and it is down 4 points over the period.

About Taysha Gene Therapies

Taysha Gene Therapies (TSHA) is a Dallas-based clinical-stage biotechnology company developing gene therapies for severe genetic disorders of the central nervous system. Its lead candidate, TSHA-102, is designed to treat Rett syndrome, a rare neurodevelopmental disorder that mainly affects girls and is caused by mutations in the MECP2 gene. The one-time therapy uses an adeno-associated virus to deliver a shortened version of the MECP2 gene directly into the spinal fluid, with a built-in control mechanism meant to keep gene expression in a safe range. TSHA-102 has Breakthrough Therapy designation from the FDA, and the company is running a pivotal trial designed to support a marketing application, along with manufacturing work to prepare for commercial supply. Taysha has no product revenue and funds development with cash raised from investors.

In Rett syndrome, Taysha competes with Acadia Pharmaceuticals, which sells Daybue, a drug that treats symptoms, and with Neurogene, which is developing another gene therapy. Its edge rests on a potential one-time treatment that addresses the underlying genetic cause, clinical data across a range of ages and a regulatory designation that brings closer FDA engagement. Investors who follow TSHA stock tend to watch data from its pivotal trial and progress toward a marketing application. Safety findings and manufacturing readiness are closely followed. Cash runway, launch planning and potential expansion into other conditions are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward TSHA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

51

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • EV/Revenue compares the whole company's value, debt included, with its sales.

37 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

25

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Know Sure Thing (KST) combines multiple rate-of-change calculations to identify long-term trend reversals.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Simple Moving Average (100-period) provides a longer-term perspective on price trends.

  • Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
55

Technical score by timeframe

ChartScoreWeight
Hourly321
Daily253
Weekly292
Monthly482

Composite score, last 90 days

05010047Aug 23, 2026Nov 19, 2026Aug 23, 2026: 51Aug 24, 2026: 50Aug 25, 2026: 51Aug 26, 2026: 50Aug 27, 2026: 49Aug 28, 2026: 48Aug 29, 2026: 49Aug 30, 2026: 49Aug 31, 2026: 48Sep 1, 2026: 50Sep 2, 2026: 48Sep 3, 2026: 47Sep 4, 2026: 48Sep 5, 2026: 49Sep 6, 2026: 49Sep 7, 2026: 49Sep 8, 2026: 49Sep 9, 2026: 46Sep 10, 2026: 45Sep 11, 2026: 45Sep 12, 2026: 45Sep 13, 2026: 45Sep 14, 2026: 45Sep 15, 2026: 44Sep 16, 2026: 44Sep 17, 2026: 47Sep 18, 2026: 45Sep 19, 2026: 45Sep 20, 2026: 45Sep 21, 2026: 45Sep 22, 2026: 47Sep 23, 2026: 45Sep 24, 2026: 44Sep 25, 2026: 43Sep 26, 2026: 43Sep 27, 2026: 43Sep 28, 2026: 45Sep 29, 2026: 45Sep 30, 2026: 45Oct 1, 2026: 42Oct 2, 2026: 41Oct 3, 2026: 41Oct 4, 2026: 41Oct 5, 2026: 41Oct 6, 2026: 40Oct 7, 2026: 40Oct 8, 2026: 41Oct 9, 2026: 41Oct 10, 2026: 41Oct 11, 2026: 41Oct 12, 2026: 39Oct 13, 2026: 37Oct 14, 2026: 37Oct 15, 2026: 37Oct 16, 2026: 38Oct 17, 2026: 38Oct 18, 2026: 38Oct 19, 2026: 40Oct 20, 2026: 41Oct 21, 2026: 41Oct 22, 2026: 40Oct 23, 2026: 39Oct 24, 2026: 40Oct 25, 2026: 40Oct 26, 2026: 40Oct 27, 2026: 42Oct 28, 2026: 42Oct 29, 2026: 42Oct 30, 2026: 42Nov 1, 2026: 43Nov 2, 2026: 40Nov 3, 2026: 41Nov 4, 2026: 43Nov 5, 2026: 41Nov 6, 2026: 43Nov 7, 2026: 43Nov 8, 2026: 43Nov 10, 2026: 43Nov 11, 2026: 43Nov 12, 2026: 45Nov 13, 2026: 49Nov 14, 2026: 49Nov 15, 2026: 49Nov 16, 2026: 48Nov 17, 2026: 48Nov 18, 2026: 48Nov 19, 2026: 47
Show the daily numbers
DateComposite
Nov 19, 202647
Nov 18, 202648
Nov 17, 202648
Nov 16, 202648
Nov 15, 202649
Nov 14, 202649
Nov 13, 202649
Nov 12, 202645
Nov 11, 202643
Nov 10, 202643
Nov 8, 202643
Nov 7, 202643
Nov 6, 202643
Nov 5, 202641
Nov 4, 202643
Nov 3, 202641
Nov 2, 202640
Nov 1, 202643
Oct 30, 202642
Oct 29, 202642
Oct 28, 202642
Oct 27, 202642
Oct 26, 202640
Oct 25, 202640
Oct 24, 202640
Oct 23, 202639
Oct 22, 202640
Oct 21, 202641
Oct 20, 202641
Oct 19, 202640
Oct 18, 202638
Oct 17, 202638
Oct 16, 202638
Oct 15, 202637
Oct 14, 202637
Oct 13, 202637
Oct 12, 202639
Oct 11, 202641
Oct 10, 202641
Oct 9, 202641
Oct 8, 202641
Oct 7, 202640
Oct 6, 202640
Oct 5, 202641
Oct 4, 202641
Oct 3, 202641
Oct 2, 202641
Oct 1, 202642
Sep 30, 202645
Sep 29, 202645
Sep 28, 202645
Sep 27, 202643
Sep 26, 202643
Sep 25, 202643
Sep 24, 202644
Sep 23, 202645
Sep 22, 202647
Sep 21, 202645
Sep 20, 202645
Sep 19, 202645
Sep 18, 202645
Sep 17, 202647
Sep 16, 202644
Sep 15, 202644
Sep 14, 202645
Sep 13, 202645
Sep 12, 202645
Sep 11, 202645
Sep 10, 202645
Sep 9, 202646
Sep 8, 202649
Sep 7, 202649
Sep 6, 202649
Sep 5, 202649
Sep 4, 202648
Sep 3, 202647
Sep 2, 202648
Sep 1, 202650
Aug 31, 202648
Aug 30, 202649
Aug 29, 202649
Aug 28, 202648
Aug 27, 202649
Aug 26, 202650
Aug 25, 202651
Aug 24, 202650
Aug 23, 202651

Key facts

Market cap
$1.2B
Sector
Healthcare
Industry
Biotechnology
Beta
1.31
Risk grade (1–10)
10
Next earnings
Nov 12, 2026

Questions

What is TSHA's stock rating today?

TSHA scores 47/100 (Weak) as of Nov 19, 2026: technical 33, fundamental 51, and news sentiment 55, which is shown but not counted. Scores are recomputed every night.

What does Taysha Gene Therapies do?

Taysha Gene Therapies (TSHA) is a Dallas-based clinical-stage biotechnology company developing gene therapies for severe genetic disorders of the central nervous system. Its lead candidate, TSHA-102, is designed to treat Rett syndrome, a rare neurodevelopmental disorder that mainly affects girls and is caused by mutations in the MECP2 gene.

Is TSHA stock a buy?

The score is not a buy or sell recommendation. A 47 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the TSHA score calculated?

99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

TSHA stock score

HTML

<a href="https://stocksscores.com/stocks/tsha/"><img src="https://stocksscores.com/stocks/tsha/badge.svg" alt="TSHA stock score" height="20"></a>

Markdown

[![TSHA stock score](https://stocksscores.com/stocks/tsha/badge.svg)](https://stocksscores.com/stocks/tsha/)